-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WwmFLnuDIrunFkn2dfJTaxXNKtBxlxP43HvXbXcp+VcscN0xHsd+FF+LHodzbwLw CD0AAm7Y1owH2MfBBNnu8g== 0000950134-08-001492.txt : 20080201 0000950134-08-001492.hdr.sgml : 20080201 20080201151559 ACCESSION NUMBER: 0000950134-08-001492 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080130 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080201 DATE AS OF CHANGE: 20080201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XENOPORT INC CENTRAL INDEX KEY: 0001130591 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943330837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51329 FILM NUMBER: 08568095 BUSINESS ADDRESS: STREET 1: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 4086167200 MAIL ADDRESS: STREET 1: 3410 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 8-K 1 f37600e8vk.htm FORM 8-K e8vk
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 30, 2008
XENOPORT, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
     
000-51329
(Commission File No.)
  94-3330837
(IRS Employer Identification No.)
3410 Central Expressway
Santa Clara, California 95051

(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (408) 616-7200
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Section 5 — Corporate Governance and Management
Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
2008 Salary Information for Named Executive Officers
On January 30, 2008, the board of directors (the “Board”) of XenoPort, Inc. (the “Company”) approved, upon the recommendation of the compensation committee of the Board, annual salaries for 2008 for the Company’s “named executive officers” (as defined under applicable securities laws). The 2008 salary information for the named executive officers is set forth on Exhibit 10.28 to this Current Report on Form 8-K, which is incorporated herein by reference.
Section 9 — Financial Statements and Exhibits
Item 9.01   Financial Statements and Exhibits.
     
Exhibit   Description
 
10.28   2008 Executive Compensation Information


 

Signatures
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  XenoPort, Inc.
(Registrant)
 
 
Dated: February 1, 2008  By:   /s/ William G. Harris    
    William G. Harris   
    Senior Vice President of Finance and Chief Financial Officer   


 

Exhibit Index
     
 
Exhibit   Description
 
10.28   2008 Executive Compensation Information

EX-10.28 2 f37600exv10w28.htm EXHIBIT 10.28 exv10w28
 

Exhibit 10.28
Executive Compensation Information
The table below provides information regarding the 2008 annual base salary of each executive officer of XenoPort, Inc. listed below:
         
Named Executive Officer   2008 Annual Base Salary
Ronald W. Barrett, PhD
Chief Executive Officer
  $ 500,000  
Kenneth C. Cundy, PhD
Senior Vice President of Preclinical Development
  $ 290,000  
Mark A. Gallop, Ph.D.
Senior Vice President of Research
  $ 281,000  
William G. Harris
Senior Vice President of Finance and Chief Financial Officer
  $ 315,000  
William J. Rieflin
President
  $ 375,000  
David R. Savello, PhD
Senior Vice President of Development
  $ 320,000  

-----END PRIVACY-ENHANCED MESSAGE-----